Micron Technology
MU
NVIDIA
NVDA
Intel
INTC
Adobe
ADBE
Salesforce
CRM
US Stock MarketDetailed Quotes
CTLT Catalent(Delisted)
- 63.480
- 0.0000.00%
Close Dec 17 16:00 ET
11.52BMarket Cap-27.84P/E (TTM)
0.000High0.000Low0Volume0.000Open63.480Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)181.51MShares63.50052wk High3.25P/B11.45BFloat Cap42.11052wk Low--Dividend TTM180.39MShs Float142.640Historical High--Div YieldTTM0.00%Amplitude18.920Historical Low--Avg Price1Lot Size
About Catalent(Delisted) Company
Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents.
Company Profile
SymbolCTLT
Company NameCatalent(Delisted)
Issue Price20.50
CEOMr. Alessandro Maselli
MarketNYSE
Employees16900
Fiscal Year Ends06-30
Websitehttps://www.catalent.com
Company Executives
- Name
- Position
- Salary
- Alessandro Maselli
- Director, Chief Executive Officer and President
- 6.58M
- Matti Masanovich
- Senior Vice President and Chief Financial Officer
- --
- Michael J. Hatzfeld, Jr
- Vice President and Chief Accounting Officer
- --
- Lisa Evoli
- Senior Vice President and Chief Human Resources Officer
- --
- Joseph A. Ferraro
- Senior Vice President, General Counsel, Chief Compliance Officer and Secretary
- --
- Karen Murphy Santiago
- Vice President and Business Transformation & Integration Officer
- --
- Scott Gunther
- Senior Vice President, Quality and Regulatory Affairs
- --
- Dr. Aristippos Gennadios
- Group President, Pharma and Consumer Health
- 3.80M
- John J. Greisch
- Executive Chairman of the Board
- 400.86K
- David McErlane
- Group President, Biologics
- --
- Ricky Hopson
- President, Division Head of BioProduct Delivery and Chief of Staff
- 972.31K
- Frank D’Amelio
- Independent Director
- --
- Dr. Donald Eugene Morel, Jr
- Independent Director
- 384.95K
- J. Martin Carroll
- Independent Director
- 426.36K
- Gregory T. Lucier
- Independent Director
- 387.61K
- Michelle R. Ryan
- Independent Director
- --
- Steven K. Barg
- Independent Director
- --
- Michael J. Barber
- Independent Director
- 374.95K
- Stephanie S. Okey, M.S.
- Independent Director
- --
- Rolf A. Classon
- Independent Director
- 384.95K
- Jack L. Stahl
- Lead Independent Director
- 395.11K
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
